New drug development in head and neck oncology
- 1 January 1984
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cis‐platinum therapy of previously treated head and neck cancer: The Southwest Oncology Group's two‐dose‐per‐month outpatient regimenMedical and Pediatric Oncology, 1980
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- Bleomycin (NSC-125066) Therapy of Responsive Solid TumorsOncology, 1976
- Combination Chemotherapy with cis-Diamminedichloroplatinum (II) and Bleomycin in Tumors of the Head and NeckOncology, 1975
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974
- 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): A comparison of drug administration at four-week and six-week intervalsPublished by Elsevier ,1973
- Early Clinical Experience with Bleomycin in the United Kingdom in Series of 105 PatientsBMJ, 1972
- Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum FactorNature, 1966
- Action du Natulan dans 94 cas de tumeurs solidesEuropean Journal of Cancer (1965), 1966
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948